EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Novel Antigen-Presenting Cell-Targeted Nanoparticles Enhance Split Vaccine Immunity Through Microneedles Inoculation

Xueliang Xiu iD, Hongyang Fu iD, Ruipeng Zhang iD, Shichao Ma iD, Panpan Guo iD, Zhipeng Li iD, Yihan Zhu, Fengsen Ma iD

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s502724 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Xueliang Xiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Zhejiang University of Technology, Deqing, 313216, People's Republic of China. Hauptthemen laut MEDLINE: Nanoparticles, Antigen-Presenting Cells, Influenza Vaccines. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim/Background: Despite their superior safety and widespread use, split vaccines typically suffer from reduced immunogenicity due to the lack of an intact viral structure. Targeting the mannose receptors on antigen-presenting cells (APCs) with nanoparticles (NPs) and delivering them via microneedles (MNs) offers a promising solution. We designed and synthesized NPs that could form complexes with split H1N1 antigens, and evaluated the immunogenicity after loading them into dissolvable microneedle arrays (dMAs).

Methods

Man-N-HACC was synthesized by conjugating mannose moieties to N-2-hydroxypropyl trimethyl ammonium chloride chitosan (N-HACC), followed by cross-linking with tripolyphosphate to form Man-N-HACC NPs. The NPs were characterized in terms of morphology, size, zeta potential, spatial orientation, macrophage internalization, and stability. The microstructure, mechanical strength, skin penetration capability, and release behavior of dMAs loaded with Man-N-HACC NPs/H1N1 complexes were investigated. Finally, the efficacy of dMAs was assessed in a rat model using ELISA and hemagglutination inhibition (HAI) assay.

Results

Characterization via Fourier transform infrared spectroscopy and nuclear magnetic resonance confirmed the synthesis of Man-N-HACC. The cross-linked generated Man-N-HACC NPs displayed uniform morphology and good stability over 28 days, along with confirmed spatial orientation of mannose ligands and macrophage internalization. The dMAs loaded with Man-N-HACC NPs/H1N1 exhibited mechanical robustness, capable of fully penetrating the skin and releasing nanovaccines. The increase in HAI titers and total IgG antibody levels in rat serum indicates the effectiveness of humoral immunity, and this effect only occurs after NPs formed post-crosslinking, rather than directly using raw nanomaterials, highlighting the critical role of the nanoparticle structure.

Conclusion

This study confirms that the delivery of Man-N-HACC NPs via dMAs provides a novel and promising approach for the administration of split influenza vaccines. Moreover, it underscores the great potential of nano-adjuvants in enhancing the efficacy of split vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesAntigen-Presenting CellsInfluenza VaccinesAnimalsInfluenza A Virus, H1N1 SubtypeRatsChitosanNeedlesMaleMannoseRats, Sprague-DawleyMannose Receptor

Stichwörter der Autor:innen

dissolvable microneedle arraysmannose receptornanoparticlessplit vaccinetarget

Substanzen

ChitosanInfluenza VaccinesMannoseMannose Receptor

Autor:innen und Institutionen

  • College of Pharmacy, Zhejiang University of Technology, Deqing, 313216, People's Republic of China.
  • Department of Dermatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, 310006, People's Republic of China.
  • Emergency Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People's Republic of China.
  • State Key Laboratory of Green Technologies for Chemical Synthesis and Conversion, College of Chemical Engineering, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.
  • Micro-nano Scale Biomedical Engineering Laboratory, Institute for Frontiers and Interdisciplinary Sciences, Zhejiang University of Technology, Hangzhou, 310014, People's Republic of China.
  • Zhejiang Provincial Key Laboratory of Quantum Precision Measurement, Hangzhou, 310023, People's Republic of China.

ORCID-Profile: Xueliang Xiu, Hongyang Fu, Ruipeng Zhang, Shichao Ma, Panpan Guo, Zhipeng Li, Fengsen Ma

Zitieren

APA

Xiu, X., Fu, H., Zhang, R., Ma, S., Guo, P., Li, Z., Zhu, Y., & Ma, F. (2025). Novel Antigen-Presenting Cell-Targeted Nanoparticles Enhance Split Vaccine Immunity Through Microneedles Inoculation. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s502724

Vancouver

Xiu X, Fu H, Zhang R, Ma S, Guo P, Li Z, et al. Novel Antigen-Presenting Cell-Targeted Nanoparticles Enhance Split Vaccine Immunity Through Microneedles Inoculation. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s502724

BibTeX
@article{Xiu2025,
  author = {Xiu, Xueliang and Fu, Hongyang and Zhang, Ruipeng and Ma, Shichao and Guo, Panpan and Li, Zhipeng and Zhu, Yihan and Ma, Fengsen},
  title = {Novel Antigen-Presenting Cell-Targeted Nanoparticles Enhance Split Vaccine Immunity Through Microneedles Inoculation},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s502724}
}
Kostenlos starten →